The experiments presented in this paper have tested the hypothesis that, in humans with peripheral artery disease (PAD)—a prototypical ischemic cardiovascular pathology [11]—there is increased production of Shh, similar to what has been previously demonstrated by our groups in various animal models of ischemia [3,12,13,14]. Here, SHH is linked to peripheral arterial disease.